$30,938.86 ownership Payment -- Novartis Pharmaceuticals to Dr. Heather Mitchell

Payment Details

AI-Powered Analysis of This Payment

The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.

Novartis Pharmaceuticals made a $30.9K ownership payment to Heather Mitchell, a Cardiology specialist in City, AZ. The payment was associated with Opdivo. Heather Mitchell received a significant ownership interest payment of $30,938.86 from Novartis Pharmaceuticals. The payment was categorized as an 'Ownership or Investment Interest' and occurred on April 25, 2024. This payment is associated with the drug Opdivo, commonly used in cardiology.

Patient Guidance: What This Payment Means for You

This information relates to an ownership interest held by a healthcare provider in a pharmaceutical company, which may influence prescribing decisions. Always discuss your treatment options with your healthcare provider and ask about alternatives.

Payment Context: Is This Amount Normal?

Ownership interests can represent a significant financial relationship between physicians and pharmaceutical companies, potentially exceeding typical per-event payments for services.

Regulatory Context: Sunshine Act Requirements

Physicians must disclose ownership interests in pharmaceutical companies as required by the Physician Payments Sunshine Act to ensure transparency in healthcare.

Related Topics

This payment is related to the following healthcare transparency topics:

• ownership-interest
• cardiology
• novartis-pharmaceuticals
• opdivo
• heather-mitchell
• payment-analysis

Understanding ownership Payments

Ownership and investment interest payments represent dividends, returns, or other financial benefits from physician ownership stakes in pharmaceutical or medical device companies. These relationships represent the most direct form of financial interest and are subject to the strictest reporting requirements under the Sunshine Act.

Frequently Asked Questions About This Payment

What was this $30.9K payment for?

This was a ownership payment of $30.9K from Novartis Pharmaceuticals to Heather Mitchell, categorized as "Ownership or Investment Interest". It was associated with Opdivo. The payment was reported under the Sunshine Act (CMS Open Payments).

Does Heather Mitchell accept pharmaceutical money?

Yes, Heather Mitchell received this $30.9K payment from Novartis Pharmaceuticals. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Heather Mitchell's full payment history on the CMS Open Payments database or on this site.

Is it legal for doctors to accept pharma payments?

Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.

Should I be concerned about this ownership payment?

A ownership payment of $30.9K should be evaluated in context. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.

How do I talk to my doctor about pharma relationships?

You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.

What types of pharma payments are most concerning?

Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.

Does pharma money affect what my doctor prescribes?

Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.

How does this compare to other doctors in Cardiology?

To compare this payment against Cardiology averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Cardiology physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.

What does this payment reveal about Heather Mitchell's relationship with Novartis Pharmaceuticals?

The payment amount is substantial, indicating a significant investment. This $30.9K ownership payment is part of the transparency data reported under the Sunshine Act.

Is this payment amount typical for Cardiology?

The payment type is 'ownership', which differs from typical consulting or speaking fees.

What should patients do after learning about this payment?

This information relates to an ownership interest held by a healthcare provider in a pharmaceutical company, which may influence prescribing decisions.

What else should I know about this ownership payment?

The date of payment is recent, falling within the 2024 reporting period.

Related Reports

• View Dr. Heather Mitchell's full payment report
• Novartis Pharmaceuticals full spending report
• Browse all Cardiology payments
• Browse all payments in Arizona
• Search for other payments